Business combinations (Details) (Onyx Pharmaceuticals, Inc. [Member], USD $) In Millions, unless otherwise specified	0 Months Ended
Sep. 30, 2013
Onyx Pharmaceuticals, Inc. [Member]
Business Acquisition [Line Items]
Total cash paid	$ 9,515
Compensation expense	197
Total consideration transferred	$ 9,712

The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

Name:	us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration